Search Results for: Avandia

Featured Stories
Metal-on-Metal Hip Replacement Device

Smith & Nephew’s Birmingham Metal-on-Metal Hip Replacement Device

Wright Medical Inc. took steps in to 2006 to convince the U.S. Food & Drug Administration (FDA) to reject pre-market approval of rival Smith & Nephew’s Birmingham metal-on-metal hip implant. Wright Medical, which makes two metal-on-metal hip replacement devices, the Conserve and the Lieneage device, filed a citizen petition ...

Read More

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

Study Linking Z-Pak to Increased Death Risk Being Reviewed by FDA

The U.S. Food & Drug Administration (FDA) is reviewing a new study that reported an increased risk of sudden, heart-related deaths among people using the antibiotic Zithromax (azithromycin), known popularly as Z-Pak. In a statement issued late yesterday, the FDA said patients being treated with Zithromax should not stop taking ...

Read More

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Lawsuit Alleges Plavix Caused Oklahoma Man to Suffer Multiple Stomach Bleeds

Another lawsuit has been filed over adverse Plavix side effects. The lawsuit, filed by national law firm Parker Waichman LLP, alleges that the blood thinner, Plavix (clopidogrel), caused an Oklahoma man to suffer from multiple stomach bleeds.

Read More

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Infuse Studies Faulted for Downplaying Side Effects

Medtronic Inc.’s published studies for its Infuse bone graft product may have downplayed serious side effects, according to an analysis published last year in The Spine Journal. The study, which drew on U.S. Food & Drug Administration (FDA) documents and other data sources, suggests that up to half of ...

Read More

Research Suggest Fracking Chemicals Can Pollute Aquifers

Research Suggest Fracking Chemicals Can Pollute Aquifers

A new study suggests fluids used during the hydraulic fracturing (fracking) process could migrate through underground fractures and contaminate water aquifers.

Read More

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos Bladder Cancer Lawsuits Continue, New Complaint Filed by Tennessee Resident

Actos bladder cancer lawsuits continue, with a new complaint filed by a resident of Tennessee. The national law firm, Parker Waichman LLP, represents the Tennessee man who alleges that Actos caused his bladder cancer.

Read More

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

U.K. Regulators Issue Additional Guidance for Metal-on-Metal Hip Implant Recipients

Regulators in the U.K. are once again issuing advice to doctors and other healthcare professionals involved in the follow-up of patients with metal-on-metal hip replacement devices. In an alert issued by the Medicines and Healthcare products Regulatory Agency (MHRA), guidance is provided for four groups of metal-on-metal hip implant ...

Read More

Actos Whistleblower Lawsuit Questions Avandia Researcher’s Financial Ties to Takeda

Actos Whistleblower Lawsuit Questions Avandia Researcher's Financial Ties to Takeda

A prominent researcher has been implicated in an alleged cover-up of Actos side effects, according to a report from TheHeart.org. An Actos whistleblower lawsuit unsealed earlier this year has alleged financial connections between the Cleveland Clinic’s Dr Steven Nissen and the maker of Actos “should be considered when analyzing Actos’s ...

Read More

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

FDA Panel Takes up Metal-on-Metal Hip Implant Safety Today

The Food and Drug Administration (FDA) is convening a meeting starting today to help decide the future of metal-on-metal hip implants following high-profile recalls and mounting questions about their overall safety.

Read More

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Indiana Woman Alleges Serious Injuries From Transvaginal Mesh Products

Parker Waichman LLP, a national law firm, just filed a lawsuit on behalf of a woman who suffered injuries after receiving transvaginal mesh implants. The lawsuit suit alleges that the transvaginal mesh created an unreasonable risk and directly caused her injuries.

Read More

States Sue Drug Makers Over Deceptive Marketing

Some states are going after drug makers in an effort to cease deceptive marketing practices and broaden possible liability for the drug industry. Up until now, noted The Wall Street Journal, industry has paid large amounts—in the billions of dollars—to … Continue reading

Posted in Legal News, Pharmaceuticals |

North Carolina man claims bladder cancer the result of taking diabetes drug Actos

A North Carolina man is the latest to claim that taking the popular type 2 diabetes drug Actos led to his bladder cancer diagnosis. The man has taken the same route as a growing number of other Americans and filed … Continue reading

Posted in Actos, Health Concerns, Legal News, Pharmaceuticals, Press Releases | Tagged , , , |

Lawsuit: Actos Caused Bladder Cancer, Wrongful Death of Wisconsin Man

A lawsuit just filed by the national law firm, Parker Waichman LLP, alleges that a Wisconsin man’s bladder cancer and wrongful death were the result of the Type 2 diabetes drug, Actos (pioglitazone). The lawsuit was filed on behalf of … Continue reading

Posted in Actos, Legal News, Pharmaceuticals |

Illinois woman’s death blamed on taking diabetes medication Actos

A recently filed lawsuit in a federal court claims that an Illinois woman died as a result of bladder cancer she developed while take the popular type 2 diabetes medication Actos. This is the latest lawsuit to claim that taking … Continue reading

Posted in Actos, Legal News, Pharmaceuticals | Tagged , |

Financial ties between researchers, drug companies taint clinical data

Much of the so-called clinical data gathered to approve new prescription drugs or used to back marketing claims a company wishes to make about its products is likely soiled by financial ties between the person who wrote the research and … Continue reading

Posted in Avandia, Legal News, Pharmaceuticals | Tagged , , |

North Carolina man claims taking Actos led to bladder cancer diagnosis

A North Carolina man is among the latest to claim that taking the popular type 2 diabetes drug Actos has caused him to be stricken with or put at risk of being diagnosed with bladder cancer. In the last year, … Continue reading

Posted in Actos, Class Action Lawsuits, Health Concerns, Legal News, Pharmaceuticals, Press Releases | Tagged |

Actos lawsuit going to trial in California in January 2013

The trial of a Mississippi man who claims to have contracted bladder cancer while taking the type 2 diabetes drug Actos is set to go to trial early next year. Jack Cooper, of Mississippi, claims he acquired bladder cancer while … Continue reading

Posted in Actos, Legal News, Pharmaceuticals | Tagged |

Actos Side Effects May Include Cataract Injuries

One of the top selling Type 2 diabetes medications in the world, Actos (pioglitazone) recently went generic, raising concerns that its expanded availability could lead to more people suffering from Actos side effects. A growing number of adverse side effects … Continue reading

Posted in Actos, Pharmaceuticals |

Actos Drug Class Poses Greater Bladder Cancer Danger Compared to Other Type 2 Diabetes Medications

For the third time in recent months, a new study has found that type 2 diabetics who take Actos face a higher risk of developing bladder cancer.  The study, which is published in the Journal of the National Cancer Institute, … Continue reading

Posted in Actos, Pharmaceuticals | Tagged |

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

Parker Waichman Representing Another Louisiana Plaintiff in Actos Bladder Cancer Lawsuit

A Louisiana man has become the latest to claim that his taking the type 2 diabetes drug Actos resulted in developing bladder cancer. He has filed a lawsuit against the Japanese manufacturer of the drug and the marketer of it … Continue reading

Posted in Actos, Pharmaceuticals | Tagged |